Market Overview

Trade CBD stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

DateResearch FirmActionCurrentTarget
11/07/17Credit SuisseUpgradesNeutralOutperform
11/03/16HSBCUpgradesReduceHold
11/09/15NomuraDowngradesBuyNeutral
Show more Loading articles...

Earnings View Earnings

Q4 2017 EST Actual Surprise
EPS: 0.3 0.33 0.03
Rev: 3.88B
Q1 2018 EST Actual Surprise
EPS: 0.13 Expected
2018-04-26
Rev:

Company Profile